Astrocytoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
| colspan="7" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="7" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan="3" rowspan="2" |Para-clinical findings | ! colspan="3" rowspan="2" |Para-clinical findings | ||
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold<br>standard''' | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
|- | |- | ||
Line 21: | Line 21: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunohistopathology | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunohistopathology | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Head-<br>ache | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Seizure | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Seizure | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Visual disturbance | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Visual disturbance | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hearing loss | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hearing loss | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Constitutional | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Constitutional | ||
! | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Focal neurological deficit | ||
|- | |- | ||
| rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |Adult primary brain tumors | | rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |Adult primary brain tumors | ||
Line 36: | Line 35: | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 73: | Line 71: | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 102: | Line 99: | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 132: | Line 128: | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 155: | Line 150: | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Endocrine abnormalities as a result of functional adenomas or pressure effect of non-functional adenomas | * Endocrine abnormalities as a result of functional adenomas or pressure effect of non-functional adenomas | ||
Line 178: | Line 172: | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 200: | Line 193: | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 225: | Line 217: | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 250: | Line 241: | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 274: | Line 264: | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 299: | Line 288: | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Hypopituitarism as a result of pressure effect on pituitary gland | * Hypopituitarism as a result of pressure effect on pituitary gland | ||
Line 322: | Line 310: | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | + vertical gaze palsy | | colspan="2" style="background: #F5F5F5; padding: 5px;" | + vertical gaze palsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* + B-hCG rise leads to precocious puberty in males | * + B-hCG rise leads to precocious puberty in males |
Revision as of 20:43, 21 January 2019
Astrocytoma Microchapters |
Diagnosis |
---|
Treatment |
Case Study |
Astrocytoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Astrocytoma differential diagnosis |
Risk calculators and risk factors for Astrocytoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Differentiating astrocytoma from other Diseases
Diseases | Clinical manifestations | Para-clinical findings | Gold standard |
Additional findings | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||
Lab Findings | MRI | Immunohistopathology | |||||||||||
Head- ache |
Seizure | Visual disturbance | Hearing loss | Constitutional | Focal neurological deficit | ||||||||
Adult primary brain tumors | Glioblastoma multiforme | + | +/− | +/− | − | − | + | − |
|
|
|
| |
Oligodendroglioma | + | + | +/− | − | − | + | − |
|
|
|
| ||
Meningioma | + | +/− | +/− | − | − | + | − |
|
|
|
| ||
Hemangioblastoma | + | +/− | +/− | − | − | + | − |
|
|
|
| ||
Pituitary adenoma | − | − | + Bitemporal hemianopia | − | − | − |
|
|
|
|
| ||
Schwannoma | − | − | +/− | + | − | − |
|
|
|
| |||
Primary CNS lymphoma | + | +/− | +/− | − | − | − |
|
|
|
| |||
Childhood primary brain tumors | Pilocytic astrocytoma | + | +/− | +/− | − | − | − |
|
|
|
| ||
Medulloblastoma | + | +/− | +/− | − | − | − |
|
|
|
| |||
Ependymoma | + | +/− | +/− | − | − | − |
|
|
|
| |||
Craniopharyngioma | + | +/− | + Bitemporal hemianopia | − | − |
|
|
|
|
| |||
Pinealoma | + | +/− | +/− | − | − | + vertical gaze palsy |
|
|
|
|
| ||
Vascular | AV malformation | + | + | − | − |
|
|
|
| ||||
Brain aneurysm | + | − | − |
|
|
|
| ||||||
Infectious | Bacterial brain abscess | + | + |
|
|
|
|
| |||||
Tuberculosis | + | + |
|
|
|
|
| ||||||
Toxoplasmosis | + |
|
|
|
|
| |||||||
Hydatid cyst | + |
+ |
|
|
|
|
| ||||||
CNS cryptococcosis | + |
|
|
|
|
| |||||||
CNS aspergillosis | + |
|
|
|
|
| |||||||
Other | Brain metastasis | + | − |
|
|
|
|